Lower Clinical Effectiveness of Oseltamivir against Influenza B Contrasted with Influenza A Infection in Children
Open Access
- 15 January 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 44 (2), 197-202
- https://doi.org/10.1086/509925
Abstract
Background. Recently, many Japanese physicians have claimed that oseltamivir is less effective in children with influenza B virus infection. This study assesses the effectiveness of oseltamivir against influenza A (H3N2) and influenza B in children on the basis of the duration of febrile illness. Methods. We used oseltamivir to treat 127 children with influenza A (H3N2; mean age, 6.97 years [range, 1–15 years]) and 362 children with influenza B (mean age, 5.16 years [range, 1–15 years]) in outpatient clinics. The duration of fever after the start of oseltamivir therapy was compared in the influenza A group and the influenza B group. Results. The mean duration of fever after the start of oseltamivir therapy was significantly greater in the influenza B group than in the influenza A (H3N2) group (2.18 days vs. 1.31 days, respectively; P < .001). The difference was marked in young children (1–5 years old; 2.37 days for the influenza B group vs. 1.42 days for the influenza A group) but was not significant among older children (11–15 years old). The 50% inhibitory concentration of oseltamivir against influenza B virus was 75.4 ± 41.7 nmol/L and was substantially higher than that for type A (H3N2) virus (0.3 ± 0.1 nmol/L). Only 3 (1.6%) of 192 influenza B viruses were resistant to oseltamivir. Conclusions. Oseltamivir is much less effective against influenza B virus infection in young children, probably because of the low sensitivity of influenza B viruses to oseltamivir. The effectiveness of oseltamivir against influenza B is influenced by age and host immunity. A few oseltamivir-resistant influenza B strains were isolated before the start of oseltamivir therapy.This publication has 16 references indexed in Scilit:
- Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practiceAntiviral Research, 2005
- Enhanced Expression of an α2,6-Linked Sialic Acid on MDCK Cells Improves Isolation of Human Influenza Viruses and Evaluation of Their Sensitivity to a Neuraminidase InhibitorJournal of Clinical Microbiology, 2005
- Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002--2003 Influenza SeasonClinical Infectious Diseases, 2005
- Resistant influenza A viruses in children treated with oseltamivir: descriptive studyThe Lancet, 2004
- Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugsVirus Research, 2004
- Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000–2002 influenza seasonsVirus Research, 2004
- [Effectiveness of oseltamivir treatment against influenza type A and type B infection in children].Kansenshogaku Zasshi, 2002
- Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant VariantsAntimicrobial Agents and Chemotherapy, 2001
- Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with OseltamivirThe Journal of Infectious Diseases, 2001
- New Approaches to Influenza ChemotherapyDrugs, 1998